ABSTRACT:To study the acceptance level of PPIUCD among women attending GMCH for delivery between January 2011 to December 2014 in relation to age, parity and mode of delivery and their complaints during follow up visit. STUDY DESIGN: Retrospective study. METHOD: In this study data of women admitted for delivery between January 2011 to December 2014 in labour room and data of women attending the postpartum OPD for PPIUCD follow up during the same period were analyzed. RESULTS: Acceptance of PPIUCD showed an increasing trend, acceptance was more among multipara and acceptance was more among clients undergoing caesarean section. 32% of the acceptors were in the age group of 26-30 years. The follow up of clients was less than 50% of the total acceptors in the four years study period. The main complaints at follow up were pain and bleeding which were dealt mainly by reassurance. The main causes of removal were for want of next child and secondly for dissatisfaction with PPIUCD. CONCLUSION: The acceptance of PPIUCD was high in this study. The PPIUCD was demonstrably safe having no serious complication reported after insertion or during follow up and low rates of expulsion. The method may be particularly beneficial in our setting where women do not come for post natal contraception counseling and usage.

OBJECTIVE: Screening mammography among 35-60 years of age group of patients has been clearly shown to reduce mortality from breast cancer. METHODS: Patients were selected from OPDs of various departments. Patients of 35-60 years of ages were included as part of the study. Detail family and menstrual history were taken and then mammography of both breasts was performed. RESULTS: Out of 60 cases coming for screening mammography, 42 were found to be some type of lesions in mammography; however 18 patients were with no findings. Commonest breast density found to be scattered areas of fibro glandular density followed by heterogeneously dense breasts. Most of the patients with heterogeneously dense breast density were found to be in their luteal phase of menstrual cycle. Lesions were classified according to BIRADS category. CONCLUSION: Screening mammography can detect various breast lesions both in symptomatic and asymptomatic individuals and thereby helping patient managements. KEYWORDS: Menstrual cycle, Luteal phase, Follicular phase, Breast, Mortality. INTRODUCTION:The use of mammography has increased rapidly over the last decade. The justification for mammographic examinations is the potential benefit they provide in detecting breast cancer at an early stage and reducing mortality. However, this benefit must be balanced against the associated potential risk of radiation carcinogenesis, economic costs, and a number of other factors. Most publications to date have used radiation risk factors and data from studies that were published over a decade ago, which now have been superseded by the results of more recent epidemiological studies. 1 It is recommended that women age 40 and older have regular mammograms. Screening is important because the earlier cancer is detected the better the chances are for successful treatment and survival. When detection occurs before any spread, the five-year survival rate is 97%. After spread to the local lymph nodes, it is 76%. After metastasis to other organs, the five-year survival rate is 20%. 2 Mammography is useful in discovering tumors too small to be felt. The procedure involves taking an X-ray of the breast with a very low radiation dose. It has been shown that there is little risk from the exposure for women over 35 who have annual mammograms. However, for younger women who are at high risk for breast cancer due to their BRCA status, exposure to X-rays may lead to an increase in risk. 1 Screening mammograms can find cancers and cases of ductal carcinoma in situ (DCIS, a noninvasive tumor in which abnormal cells that may become cancerous build up in the lining of breast ducts) that need to be treated. False-positive results occur when radiologists decide mammograms are abnormal but no cancer is actually present. False-positive results are more common for younger women, women who have had previous breast biopsies, women with a family history of breast cancer, and women who are taking estrogen (For example, menopausal hormone therapy).False-negative results occur when ma...